Audit of Therapeutic Drug Monitoring

Marks V. A historical introduction. In: Widdop B , ed. Therapeutic Drug Monitoring. Edinburgh: Churchill Livingstone, 1985: 3–15.

Marks V Lindup WE Baylis EM . Measurement of therapeutic drugs. Adv Clin Chem 1973; 16: 47–109.

Koch-Weser J . Drug therapy: Serum drug concentrations as therapeutic guides. N Engl J Med 1972; 287: 227–31.

Koch-Weser J . The serum level approach to individualisation of drug dosage. Eur J Clin Pharmacol 1975; 9: 1–8.

Morgan DB . Plasma digoxin—an over-used test? Ann Clin Biochem 1984; 21: 449–52.

Editorial. What therapeutic drugs should be monitored? Lancet 1985; ii: 309–10.

Brodie MJ McIntosh ME Hallworth MJ . Therapeutie drug monitoring—the need for audit. Scott Med J 1985; 30: 75–82.

Gibb I Cowan JC Parnham AJ Thomas TH . Use and misuse of a digoxin assay service. Br Med J 1986; 293: 678–80.

Bailie GR Angaran MS . Evaluation of the use and outcome of serum digoxin assays. Pharm J 1986; 236: 392–3.

Chadwick DW . Overuse of monitoring of blood concentrations of antiepileptic drugs. Br Med J 1987; 294; 723–4.

Dobbs RJ Nicholson PW Denham MJ Therapeutic drug monitoring of digoxin—help or hindrance? Eur J Clin Pharmacol 1986; 31: 491–5.

Mucklow JC . Therapeutic drug monitoring—can it improve the treatment of epilepsy? J Clin Hosp Pharm 1982; 7: 79–85.

Werner M Sutherland EW Abramson FP . Concepts for the rational selection of assays to be used in monitoring therapeutic drugs. Clin Chem 1975; 21: 1368–71.

Perucea E Richens A. Antiepileptic drugs: clinical aspects. In: Richens A Marks V , eds. Therapeutic Drug Monitoring. Edinburgh: Churchill Livingstone, 1981; 320–48.

Schobben F van der Kleijn E Vree TB . Therapeutic monitoring of valproic acid. Ther Drug Monit 1980; 2: 61–71.

Minns RA Brown JK Blackwood DHR McQueen JK . Valproate levels in children with epilepsy. Lancet 1982; i: 677–8.

Williams J. Quality control of therapeutic drug assays. In: Widdop B , ed. Therapeutic Drug Monitoring. Edinburgh: Churchill Livingstone, 1985; 95–114.

Levin B Cohen SS Birmingham PH . Effect of pharmacist intervention on the use of serum drug assays. Am J Hosp Pharm 1981; 38: 845–51.

Hendricks JN . Audit Criteria For Drug Utilisation Review. Bethesda, MD: American Society of Hospital Pharmacists. 1981 (vol 1) & 1983 (vol 2).

Guernsey BG Ingrim NB Hokanson JA A utilisation review of theophylline assays: sampling patterns and use. Drug Intell Clin Pharm 1984; 18: 906–12.

Anderson AC Hodges GR Barnes WG . Determination of serum gentamicin sulphate levels. Arch Intern Med 1976; 136: 785–7.

Slaughter RL Scheider PJ Visconti JA . Appropriateness of the use of serum digoxin and digitoxin assays. Am J Hosp Pharm 1978; 35: 1376–9.

Floyd RA Taketomo R . Serum drug level usage review—a clinical pharmacy service. Drug Intell Clin Pharm 1979; 13: 44–5.

Harless GR . Clinical use of serum theophylline assays in a community hospital. Am J Hosp Pharm 1981; 38: 901–2.

Pasko MT Mylotte JM Boh LE . Evaluation of the use of laboratory tests in monitoring tobramycin therapy. Am J Hosp Pharm 1981; 38: 1956–7.

Gentry SM . Keith TD, McMillan DM, Goetter WE. Evaluation of the ordering of serum theophylline concentrations. Am J Hosp Pharm 1981; 38: 1937–9.

Gotz VP Lopez LM Reeves SE Morrow ME . Clinical utilisation of serum theophylline concentrations in a university-affiliated hospital. Drug Intell Clin Pharm 1982; 16: 872–4.

Clague HW Twum-Barima Y Carruthers SG . An audit of requests for therapeutic drug monitoring of digoxin: problems and pitfalls. Ther Drug Monit 1983; 5: 249–54.

Bussey HI Hoffman EW . A prospective evaluation of therapeutic drug monitoring. Ther Drug Monit 1983; 5: 245–8.

Beardsley RS Freeman JM Appel FA . Anticonvulsant serum levels are useful only if the physician appropriately uses them: an assessment of the impact of providing serum level data to physicians. Epilepsia 1983; 24: 330–5.

Moulds RFW Johnson GJ Bury RW . Audit of theophylline assay service. Lancet 1985; ii: 550.

Horn JR Christensen DB de Blaquiere PA . Evaluation of a digoxin pharmacokinetic monitoring service in a community hospital. Drug Intell Clin Pharm 1985; 19: 45–52.

Sargenti C Zelman L Beauclair T Evaluation of appropriateness and interpretation of serum theophylline assays. Drug Intell Clin Pharm 1985; 19: 380–4.

Doran JF . Requests for digoxin assays. Lancet 1986; i: 321–2.

Guest K McLean AJ Wellington CV . Drug assay services and therapeutic drug use in a general hospital. Med J Aust 1980; 1: 167–70.

Hallworth MJ Brodie MJ . Withering look at serum digoxin requests. Lancet 1986; i: 95–6.

Bonati M Traina GL Colombo F Tognoni G. Digoxin serum requests. Lancet 1986; i: 623–4.

Adams DN . The Hitch-hiker's Guide to the Galaxy. London: Pan Books, 1979; 136.

Rowland M Tozer TN . Clinical pharmacokinetics: Concepts and Applications. Philadelphia: Lea & Febiger, 1980; 100, 179.

Kelman AW Whiting B Bryson SM . OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics. Br J Clin Pharmacol 1982; 14: 247–56.

Friedman H Greenblatt DJ . Rational therapeutic drug monitoring. JAMA 1986; 256: 2227–33.

Rylance GW Moreland TA . Drug level monitoring in paediatric practice. Arch Dis Child 1980; 55: 89–98.

Aronson JK . Indications for the measurement of plasma digoxin concentrations. Drugs 1983; 26: 230–42.

Aronson JK . Digoxin. In: Widdop B , ed. Therapeutic Drug Monitoring. Edinburgh: Churchill Livingstone, 1985; 182–210.

Brodie MJ Forrest G Rapeport WG . Carbamazepine 10,11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants. Br J Clin Pharmacol 1983; 16: 747–50.

Butler TC . Some quantitative aspects of the pharmacology of phenobarbital. In: Pippenger CE Penry JK Kutt H , eds. Antiepileptic Drugs: Quantitative Analysis and Interpretation. New York: Raven Press, 1978; 261–71.

Shorvon SD . Reynolds EH. Early prognosis of epilepsy. Br Med J 1982; 285: 1699–701.

Brodie MJ . The optimum use of anticonvulsants. Practitioner 1985; 229: 921–7.

Reynolds EH . Serum levels of anticonvulsant drugs: interpretation and clinical value. Pharmacol Ther 1980; 8: 217–35.

Elenbaas RM Payne VW Bauman JL . Influence of clinical pharmacist consultations on the use of drug blood level tests. Am J Hosp Pharm 1980; 37: 61–4.

Kimelblatt BJ Bradbury K Chodoff L Costbenefit analysis of an aminoglycoside monitoring service. Am J Hosp Pharm 1986; 43: 1205–09.

Richardson T . The effect of computer generated comments on the distribution of anticonvulsant concentrations. Ann Clin Biochem 1984; 21: 184–7.

Koren G Soldin SJ MacLeod SM . Organisation and efficiency of a therapeutic drug monitoring consultation service in a pediatric hospital. Ther Drug Monit 1985; 7: 295–8.

Whiting B Kelman AW Bryson SM Therapeutic drug monitoring. Lancet 1985; ii: 497–8.